¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"acquired tolerance"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
cross-tolerance
±³Â÷³»¼º
drug tolerance
¾à¹°³»¼º, ¾à¹°ÀúÇ×¼º
exercise tolerance test
¿îµ¿³»¼º°Ë»ç
glucose tolerance test
´çºÎÇϰ˻ç
high dose tolerance
Ç׿ø°ú·®Çã¿ë
high zone tolerance
Ç׿ø°ú·®Çã¿ë
immunologic tolerance
¸é¿ªÇã¿ë
low-dose tolerance
Ç׿ø¼Ò·®Çã¿ë
low-zone tolerance
Ç׿ø¼Ò·®Çã¿ë
maximum tolerance dose
1. ÃÖ´ë³»¾à¿ë·®, ÃÖ´ë³»¾à·® 2. ÃÖ´ë°ßµõ¼±·®
median tolerance limit
¹Ý¼ö»ýÁ¸ÇѰè³óµµ
oral glucose tolerance test
°æ±¸Æ÷µµ´ç³»¼º°Ë»ç
organ tolerance dose
±â°ü°ßµõ¼±·®
oxygen tolerance
»ê¼Ò³»¼º
self-tolerance
1. ÀÚ°¡°ü¿ë 2. ÀÚ°¡³»¼º
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
acceleration tolerance
°¡¼Ó³»¼º
adoptive tolerance
ÀÔ¾ç¸é¿ªÇã¿ë
cross-tolerance
±³Â÷³»¼º
carbohydrate tolerance test
ź¼öȹ°³»¼º½ÃÇè
cortisone glucose tolerance test
ÄÚ¸£Æ¼¼ÕÆ÷µµ´çºÎÇϽÃÇè
cross tolerance
±³Â÷³»¼º
drug tolerance
¾à¹°³»¼º, ¾à¹°ÀúÇ×¼º
maximum tolerance dose
ÃÖ´ë³»¾à¿ë·®, ÃÖ´ë³»¾à·®, ÃÖ´ë°ßµõ¼±·®
organ tolerance dose
±â°ü°ßµõ¼±·®
tolerance dose
°ßµõ¼±·®
exercise tolerance test
¿îµ¿³»¼º°Ë»ç
glucose insulin tolerance test
Æ÷µµ´çÀν¶¸°°ßµõ°Ë»ç
glucose tolerance test
Æ÷µµ´ç°ßµõ°Ë»ç
heat tolerance
³»¿¼º
heparin tolerance test
ÇìÆÄ¸°³»¼º°Ë»ç
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
acquired heart disease =AHD
ÈÄõ¼º ½ÉÁúȯ(¡ãýòðü´).
acquired hyperoxaluria
ÈÄõ¼º °í¼ö»ê´¢Áõ
acquired ichthyosis
ÈÄõ¼º(ýô¸àõ)¾î¸°¼±(åà×÷àÈ)
acquired immune deficiency
ÈÄõ¼º ¸é¿ª°áÇÌ
acquired immune deficiency syndrome
ÈÄõ¼º ¸é¿ª°áÇÌ ÁõÈıº
acquired immune deficiency syndrome
ÈÄõ¼º ¸é¿ª°áÇÌÁõÈıº(ýô¸àõ Øóæ¹ÌÀù¹ñøý¦ÏØ)
acquired immunity
ÈÄõ¼º ¸é¿ª, ½Å°æÈ¹µæ¸é¿ª(üòÔðØóæ¹).
acquired immunodeficiency syndorme
ÈÄõ¼º ¸é¿ª°áÇÌ ÁõÈıº(ýô¸àõ Øóæ¹ÌÀù¹ ñøý¦ÏØ)
acquired immunodeficiency syndrome
ÈÄõ¼º¸é¿ª°áÇÌÁõ
acquired immunodeficiency syndrome
ÈÄõ¼º ¸é¿ª°áÇÌ ÁõÈıº
acquired immunodeficiency syndrome (AIDS)
ÈÄõ¼º¸é¿ª°áÇÌÁõ(Èıº)
acquired immunodeficiency syndrome(AIDS)
ÈÄõ¼º ¸é¿ª°áÇÌ ÁõÈıº
acquired perforating dermatosis
ÈÄõ¼º õ°ø¼º ÇǺκ´
acquired porphyria cutanea tarda
ÈÄõ¼º Áö¿¬¼º ÇǺΠÆ÷¸£ÇǸ°Áõ(~ñø)
acquired progressive lymphangioma
ÈÄõ¼º ÁøÇ༺ ¸²ÇÁ°üÁ¾
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
acquired immune deficiency syndrome
ÈÄõ¼º ¸é¿ª°áÇÌÁõÈıº(ýô¸àõ Øóæ¹ÌÀù¹ñøý¦ÏØ)
acquired immunity
ÈÄõ¼º ¸é¿ª, ½Å°æÈ¹µæ¸é¿ª(üòÔðØóæ¹).
acquired immunodeficiency syndorme
ÈÄõ¼º ¸é¿ª°áÇÌ ÁõÈıº(ýô¸àõ Øóæ¹ÌÀù¹ ñøý¦ÏØ)
acquired immunodeficiency syndrome
ÈÄõ¼º ¸é¿ª°áÇÌ ÁõÈıº
acquired immunodeficiency syndrome
ÈÄõ¼º¸é¿ª°áÇÌÁõ
acquired immunodeficiency syndrome (AIDS)
ÈÄõ¼º¸é¿ª°áÇÌÁõ(Èıº)
acquired immunodeficiency syndrome(AIDS)
ÈÄõ¼º ¸é¿ª°áÇÌ ÁõÈıº
acquired perforating dermatosis
ÈÄõ¼º õ°ø¼º ÇǺκ´
acquired porphyria cutanea tarda
ÈÄõ¼º Áö¿¬¼º ÇǺΠÆ÷¸£ÇǸ°Áõ(~ñø)
acquired progressive lymphangioma
ÈÄõ¼º ÁøÇ༺ ¸²ÇÁ°üÁ¾
acquired reactive perforating dermatosis
ÈÄõ¼º ¹ÝÀÀ¼º õ°ø¼º ÇǺκ´
acquired resistence
ȹµæÀúÇ×¼º(¡î½ù÷àõ).
aids=£¾acquired immune deficiency syndrome
ÈÄõ¼º¸é¿ª°áÇÌÁõÈıº(ýô¸àõØóæ¹ÌÀù¹ñøý¦ÏØ)
hospital acquired (nosocomial) infection
¿ø³»°¨¿°(êÂÒ®Êïæø), º´¿ø°¨¿°.
hospital acquired (nosocomial) infection
¿ø³»°¨¿°, º´¿ø°¨¿°.
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½